Abstract:2003 Background: Recent data indicate that initiation and maintenance of several cancers including glioblastoma (GBM) may be driven by a small subset of cells called tumor stem cells. A key feature necessary to maintain stem cells is self-renewal. However, the mechanisms underlying GBM stem cell (GSC) self-renewal remain unknown. We identified STAT3 as a key transcription factor associated with poor outcome and treatment resistance in GBM. STAT3 is also an important regulator of self-renewal in several stem cell types. We thus tested the hypothesis that targeting STAT3 with a novel small molecule inhibitor would block GSC self-renewal. Methods: GSC neurosphere cultures from 12 human GBM tumors were expanded under serum free conditions. Self-renewal of GSCs was quantified by neurosphere formation efficiency. Synthesis and analysis of over 150 caffeic acid analogs was performed to identify the novel and potent STAT3 inhibitor WP1193. Results: Western blot analysis demonstrated that STAT3 was activated and phosphorylated (ser727 and tyr705) at high levels in 10 out of 12 GSC neurosphere cultures undergoing self-renewal. Treatment of GSCs with WP1193 at increasing concentrations from 0 to 10uM resulted in a dose dependent decrease in cell proliferation and neurosphere formation in all GSC lines tested, with an associated decrease in both total and phosphorylated STAT3. Treatment with WP1193 at 5uM for 48 hrs was sufficient to completely eliminate self-renewal and neurosphere formation at 14 days under limiting dilution conditions versus untreated controls (control neurosphere formation efficiency 12–40%). Quantitative RT-PCR and FACS analysis of CD133, a putative marker of GBM stem cells, showed a significant depletion of CD133 positive cells after WP1193 treatment (>5uM). Cell cycle analysis demonstrated that WP1193 treatment also significantly reduced the number of cells in S-Phase and significantly increased G1 arrest compared to matched controls of untreated or temozolomide treated GSCs. Conclusions: These data indicate that STAT3 is potentially important regulator of GSC self-renewal that is also associated treatment resistance in GBM. WP1193 is a potent inhibitor of GSC self-renewal and is a promising agent for therapeutically targeting GSCs. No significant financial relationships to disclose.

A Noval STAT3 Pathway Inhibitor Suppresses the Self-renewal and Induces Apoptosis in Glioblastoma Stem Cells

Effect of A Small Molecule Inhibitor of the Jak2/Stat3 Pathway on Self-Renewal of Glioblastoma Stem Cells

Induction of Cell-Cycle Arrest and Apoptosis in Glioblastoma Stem-Like Cells by WP1193, a Novel Small Molecule Inhibitor of the JAK2/STAT3 Pathway

STEM-43. GSK3β PROMOTES THE BMX-MEDIATED STAT3 ACTIVATION TO MAINTAIN GLIOBLASTOMA STEM CELLS

Knockdown of STAT3 Expression by RNAi Suppresses Growth and Induces Apoptosis and Differentiation in Glioblastoma Stem Cells.

Antitumor Activity Of Novel Pyrazole-Based Small Molecular Inhibitors Of The Stat3 Pathway In Patient Derived High Grade Glioma Cells

Inhibition of Mesenchymal Phenotypes in Glioblastoma by Combined Targeting of NF-κB and STAT3 Pathways

Induction of Autophagy in GSC by a STAT3 Pathway Inhibitor

Pyrimidine Compounds By4003 and By4008 Inhibit Glioblastoma Cells Growth Via Modulating Stat3 Signaling Pathway

Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells

Cardamonin Induces Apoptosis by Suppressing STAT3 Signaling Pathway in Glioblastoma Stem Cells

Synthetic Lethality Through GSK3 Inhibition in Glioma Stem Cells Via the WNT-WWC1-YAP Axis

STAT3 Silencing with Lentivirus Inhibits Growth and Induces Apoptosis and Differentiation of U251 Cells

Dual PLK1 and STAT3 Inhibition Promotes Glioblastoma Cells Apoptosis Through MYC

Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells.

STAT3 inhibition induced temozolomide-resistant glioblastoma apoptosis via triggering mitochondrial STAT3 translocation and respiratory chain dysfunction.

Targeting Stat3 Suppresses Growth of U251 Cell-Derived Tumours in Nude Mice

Glioma Stem-Like Cells Evade Interferon Suppression Through MBD3/NuRD Complex-Mediated STAT1 Downregulation

The role of STAT3 activation in modulating the immune microenvironment of GBM

The Inhibition Study of STAT3 Sirna on Glioblastoma Stem Cells

Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy